TNXP - Tonix Pharmaceuticals Holding Corp.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development17,55813,34228,53335,504
Selling General and Administrative8,7647,94910,43612,658
Non Recurring----
Others----
Total Operating Expenses26,32221,29138,96948,162
Operating Income or Loss-26,322-21,291-38,969-48,162
Income from Continuing Operations
Total Other Income/Expenses Net233368127108
Earnings Before Interest and Taxes-26,322-21,291-38,969-48,162
Interest Expense----
Income Before Tax-26,089-21,123-38,842-48,054
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-26,089-21,123-38,842-48,054
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-26,089-21,123-38,842-48,054
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-29,355-21,123-38,842-48,054